» Articles » PMID: 36001500

Quantifying Articulatory Impairments in Neurodegenerative Motor Diseases: A Scoping Review and Meta-analysis of Interpretable Acoustic Features

Overview
Date 2022 Aug 24
PMID 36001500
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Neurodegenerative motor diseases (NMDs) have devastating effects on the lives of patients and their loved ones, in part due to the impact of neurologic abnormalities on speech, which significantly limits functional communication. Clinical speech researchers have thus spent decades investigating speech features in populations suffering from NMDs. Features of impaired articulatory function are of particular interest given their detrimental impact on intelligibility, their ability to encode a variety of distinct movement disorders, and their potential as diagnostic indicators of neurodegenerative diseases. The objectives of this scoping review were to identify (1) which components of articulation (i.e. coordination, consistency, speed, precision, and repetition rate) are the most represented in the acoustic literature on NMDs; (2) which acoustic articulatory features demonstrate the most potential for detecting speech motor dysfunction in NMDs; and (3) which articulatory components are the most impaired within each NMD.

Method: This review examined literature published between 1976 and 2020. Studies were identified from six electronic databases using predefined key search terms. The first research objective was addressed using a frequency count of studies investigating each articulatory component, while the second and third objectives were addressed using meta-analyses.

Result: Findings from 126 studies revealed a considerable emphasis on articulatory precision. Of the 24 features included in the meta-analyses, vowel dispersion/distance and stop gap duration exhibited the largest effects when comparing the NMD population to controls. The meta-analyses also revealed divergent patterns of articulatory performance across disease types, providing evidence of unique profiles of articulatory impairment.

Conclusion: This review illustrates the current state of the literature on acoustic articulatory features in NMDs. By highlighting the areas of need within each articulatory component and disease group, this work provides a foundation on which clinical researchers, speech scientists, neurologists, and computer science engineers can develop research questions that will both broaden and deepen the understanding of articulatory impairments in NMDs.

Citing Articles

Clinical Decision Support Using Speech Signal Analysis: Systematic Scoping Review of Neurological Disorders.

De Silva U, Madanian S, Olsen S, Templeton J, Poellabauer C, Schneider S J Med Internet Res. 2025; 27:e63004.

PMID: 39804693 PMC: 11773292. DOI: 10.2196/63004.


Global perspectives on the management of primary progressive aphasia.

Gallee J, Cartwright J, Grasso S, Jokel R, Lavoie M, McGowan E Sci Rep. 2024; 14(1):19712.

PMID: 39181907 PMC: 11344800. DOI: 10.1038/s41598-024-70156-5.


Multimodal speech biomarkers for remote monitoring of ALS disease progression.

Neumann M, Kothare H, Ramanarayanan V Comput Biol Med. 2024; 180:108949.

PMID: 39126786 PMC: 11357899. DOI: 10.1016/j.compbiomed.2024.108949.


Combining Multiple Multimodal Speech Features into an Interpretable Index Score for Capturing Disease Progression in Amyotrophic Lateral Sclerosis.

Neumann M, Kothare H, Ramanarayanan V Interspeech. 2024; 2023:2353-2357.

PMID: 39006832 PMC: 11246072. DOI: 10.21437/interspeech.2023-2100.


Multimodal Speech Biomarkers for Remote Monitoring of ALS Disease Progression.

Neumann M, Kothare H, Ramanarayanan V medRxiv. 2024; .

PMID: 38978682 PMC: 11230328. DOI: 10.1101/2024.06.26.24308811.


References
1.
Lam J, Tjaden K . Clear Speech Variants: An Acoustic Study in Parkinson's Disease. J Speech Lang Hear Res. 2016; 59(4):631-46. PMC: 5280060. DOI: 10.1044/2015_JSLHR-S-15-0216. View

2.
Yunusova Y, Green J, Greenwood L, Wang J, Pattee G, Zinman L . Tongue movements and their acoustic consequences in amyotrophic lateral sclerosis. Folia Phoniatr Logop. 2012; 64(2):94-102. PMC: 3369262. DOI: 10.1159/000336890. View

3.
Kent R, Kim Y . Toward an acoustic typology of motor speech disorders. Clin Linguist Phon. 2003; 17(6):427-45. DOI: 10.1080/0269920031000086248. View

4.
Munn Z, Peters M, Stern C, Tufanaru C, McArthur A, Aromataris E . Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018; 18(1):143. PMC: 6245623. DOI: 10.1186/s12874-018-0611-x. View

5.
Ho A, Iansek R, Marigliani C, Bradshaw J, Gates S . Speech impairment in a large sample of patients with Parkinson's disease. Behav Neurol. 2012; 11(3):131-7. View